Skin fungal infection. Tinea corporis
Conditions
Interventions
Intervention 1: Intervention group 1 will receive silicone gel containing two antifungal compounds, terbinafine and thymol. The amount of terbinafine is 1% and the amount of thymol is 3%. This is the
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients who have been ill for fewer than 7 days will be included in the study. All patients who are positive for dermatophyte filaments on 10% KOH mount and have less than 20% of their body surface area involved will be included in the study. No other skin disease should be reported. Erythema, scaling rash, and itching should be at least 2 numbers.
Exclusion criteria
Exclusion criteria: Patients with diabetes, HIV, diseases and immune system problems will not be included in the study. Patients with a history of hypersensitivity reactions to terbinafine were not included in the study. Individuals who are using topical or systemic corticosteroids, antibiotics, or antifungal treatments, or have used them within four weeks prior to the start of the study, will not be included in the study. Pregnant, lactating women, or those planning to become pregnant were not included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of fungal infection. Timepoint: Before intervention (day 0), and after intervention (day 15). Method of measurement: Potassium hydroxide (KOH) preparation test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythema at the site of infection. Timepoint: Before intervention (day 0), and after intervention (day 15). Method of measurement: Visual assessment.;Scaling at the site of infection. Timepoint: Before intervention (day 0), and after intervention (day 15). Method of measurement: Visual assessment.;Burning/itching sensation at the site of infection. Timepoint: Before intervention (day 0), and after intervention (day 15). Method of measurement: visual analogue scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactCyrus Jalili
Kermanshah University of Medical Sciences
Outcome results
None listed